Q4 2024 Earnings Conference Call February 14, 2025 3:00 AM ETCompany ParticipantsMasamichi Terabatake - Group President ...

A neuroanatomical minimal network model was revisited to elucidate the mechanism of salt concentration memory-dependent chemotaxis observed in Caenorhabditis elegans. C. elegans memorizes the salt ...

My name is Daniel Meyer, VP and head of investor relations. Our earnings press release and investor spreadsheet is now ...

The cell and gene therapies in rare disorders market is expected to grow at a significantly high rate during the forecast period (2025–2034) and main ...

This valuable study reports on the critical role of ANKRD5 (ANKEF1) in sperm motility and male fertility. However, the supporting data remain incomplete. This work will be of interest to biomedical ...

Making decisions is an important part of leadership. But being decisive is an art. These tech leaders have mastered it.

Vincent Gaynor remembers, almost to the minute, when he realized his part in birthing the breakthrough gene therapy Zolgensma ...

The Procter & Gamble Company ( NYSE: PG) Consumer Analyst Group of New York Conference Call February 20, 2025 9:00 AM ET Andre Schulten - Chief Financial Officer John Chevalier - Senior Vice President ...

Ladies and gentlemen, thank you for standing by, and welcome to the Welltower Fourth Quarter 2024 Earnings Conference Call. (Operator Instructions) I will now hand today's call over to Matt McQueen, ...

Hello and welcome to Inseego Corp's fourth quarter and full-year 2024 financial results conference call. Please note that today's event is being recorded. (Operator Instructions) On the call today are ...

“The challenge is that almost half of the budget is nominally exempt from cuts – Trump said he would not touch social ...

Welcome to the Confluent Q4 and fiscal year 2024 earnings conference call. I'm Shane Xie from investor relations, and I'm ...